Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SAFE Pharmaceutical is a China-based contract research organization focused on innovative drug R&D services rather than development of its own therapeutic pipeline. Founded in 2016, the company operates as a one-stop CRO platform providing drug discovery support, antibody discovery, AI-driven and organoid-based early screening, pharmacology, DMPK, nonclinical safety evaluation, central laboratory and companion diagnostics services, and NMPA/FDA regulatory support. The company also highlights integrated capabilities for radiopharmaceutical R&D and production technologies and has participated in partnerships around the cell and gene therapy ecosystem. Its footprint includes sites in Beijing, Gu'an, Suzhou, Shenzhen, Wuxi, and a U.S. presence in Great Falls, Virginia. SAFE Pharmaceutical appears to serve biotech and pharmaceutical clients globally as a service provider rather than as a product-focused biotech sponsor.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SAFE Pharmaceutical.